186 results
Page 9 of 10
6-K
EX-99.1
9y5sy
26 Aug 14
RepliCel Announces 2014 Second Quarter Financial Results
12:00am
6-K
EX-99.2
qvwo4y
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
c1d14a8fmla uoz18
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
6-K
EX-99.1
m9bb 3hm5k50us365i
23 Jun 14
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
12:00am
6-K
EX-99.1
v53yd2ir m5csz04f
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am
6-K
EX-99.1
7jk2vzu8gkzjvf8
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.2
42p8aa
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
0butlsn7ve3 fnn3i75
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
yjyyoyx
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.1
f1kvzwg ou87ln8m
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.2
pz8121 6i9df
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
sl1luqdy be8o3
18 Mar 14
RepliCel Reports 2013 Annual Financial Results
12:00am
6-K
EX-99.1
srmxw3p
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
ssdr0vj5xl3wh1iim82
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
piketa2qnto9v204vzl3
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99
q7s4g3jg4lckxv
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
bqs 76c85gkxg36odc
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.2
5in wbf0yzpc
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.1
42umegs 21es
28 Aug 13
Current report (foreign)
12:00am